Saudi Critical Care Journal

REVIEW ARTICLE
Year
: 2017  |  Volume : 1  |  Issue : 6  |  Page : 28--30

The bacteremia antibiotic length actually needed for clinical effectiveness research program (balance.ccctg.ca)


Nick Daneman, Asgar Rishu, Robert Fowler 
 Sunnybrook Hospital, the University of Toronto, Toronto, Ontario, Canada

Correspondence Address:
Robert Fowler
MDCM, MS (Epi), FRCP(C), 2075 Bayview Avenue, Room D478, Sunnybrook Hospital, Toronto, Ontario
Canada

A multitude of global health organizations have declared antimicrobial resistance a threat to health, based on rapidly increasing resistance rates and declining new drug development. Up to 30%–50% of antibiotic use is estimated to be inappropriate, and excessive durations of treatment are the greatest contributor to inappropriate use. A landmark trial in critically ill patients with ventilator-associated pneumonia showed that mortality and relapse rates were noninferior in patients who received 8 versus 15 days of treatment, but similar evidence is lacking for the treatment of patients with bloodstream infection, which affects 15% of critically ill patients. The Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) research program was initiated to provide evidence-based guidance on this question.


How to cite this article:
Daneman N, Rishu A, Fowler R. The bacteremia antibiotic length actually needed for clinical effectiveness research program (balance.ccctg.ca).Saudi Crit Care J 2017;1:28-30


How to cite this URL:
Daneman N, Rishu A, Fowler R. The bacteremia antibiotic length actually needed for clinical effectiveness research program (balance.ccctg.ca). Saudi Crit Care J [serial online] 2017 [cited 2022 Jan 17 ];1:28-30
Available from: https://www.sccj-sa.org/article.asp?issn=2543-1854;year=2017;volume=1;issue=6;spage=28;epage=30;aulast=Daneman;type=0